MedTrace Logo

Study to Know the Efficacy of Higher Doses of Pralidoxime in Patients of Organophpsphorus Poisoning.

NCT00333944 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2006-06-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether high doses of pralidoxime(PAM) are effective as compare to lower doses of PAM in the management of moderately sever organophosphorus poisoning patients.

Conditions

  • Acute Organophosphorus Pesticide Poisoning

Interventions

DRUG

Pralidoxime(drug)

Sponsors & Collaborators

  • Giriraj Hospital

    lead OTHER

Principal Investigators

  • Kirti S Pawar, MBBS,DA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-05-31
Completion
2003-06-30

Countries

  • India

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00333944 on ClinicalTrials.gov